Etiketter

Visar inlägg med etikett Angiogeneesin säätely. Visa alla inlägg
Visar inlägg med etikett Angiogeneesin säätely. Visa alla inlägg

tisdag 11 december 2012

Miten uudet verisuonet versovat endoteelistä ? Angiogeneesista

http://cardiovascres.oxfordjournals.org/content/78/2/203.full
Tässä on tosiaan pohdittavaa moneksi päiväksi.

 Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead

Abstract

Sprouting angiogenesis is an invasive process that involves proteolytic activities required for the degradation of the endothelial basement membrane, cell migration with removal of obstructing matrix proteins, and generation of space in the matrix to allow endothelial cells to form a proper lumen.

 In the last decade it has become clear that besides these matrix-degrading properties, proteases exert additional, more subtle functions that play a key role in angiogenesis. These functions are discussed with specific emphasis on membrane type-1 matrix metalloproteinase (MT1-MMP), other MMPs, and the related ADAMs (a disintegrin and metalloproteinase domain).

 Proteases modulate the balance between pro- and anti-angiogenic factors by activation and modification of growth factors and chemokines, ectodomain shedding with accompanied receptor activation, shedding of cytokines from membrane-bound precursors, and generation of (matrix) protein fragments that inhibit or activate angiogenesis. 

Furthermore, they participate in the recruitment of leukocytes and progenitor cells, which contribute to the onset and progression of angiogenesis. 
 Proteases facilitate the mobilization of progenitor cells in the bone marrow as well as the entry of these cells and leukocytes into the angiogenic area. 

The interaction between pericytes and the newly formed endothelial tubes is accompanied by silencing of MMP activities. 

 Better understanding of the various activities of proteases may be helpful in developing more specific inhibitors that could result in tailor-made modification of proteolytic activities in disease.

fredag 13 januari 2012

Angiogeneesin säätely silmässä

Angiogeneesistä uusi väitöskirja. MMP osallistuu angiogeneesin säätelyyn.Oftalmologian alalta väitöskirja.

Bourghardt Peebo, Beatrice. Angiogenesis from a new perspective Linköpings universitet Institutionen för klinisk och experimentell medicin. Oftalmologi. 
ISBN 978-91-7519-999-3
Linköping : Linköping University Electronic Press, 2012
English 91 s.
Series: Linköping University Medical Dissertations, 0345-0082 ; 1284
Read full text (fulltext)
  • Doctoral thesis (other academic)
Abstract Subject headings
Background 
Sitaatti: 
Huomaa MMP  ja TIMP  joukossa. 
Activators  Function
  • VEGF family members Stimulate vasculogenesis/angiogenesis, permeability, leukocyte adhesion
  • Angiopoietin1, Tie2 Stabilize vessels, inhibit permeability
  • PDGF Recruit pericytes, smooth muscle cells
  • TGF-ß1, endoglin, TGF-ß-receptors Stimulate ECM production, recruit macrophages
  • FGF, HGF, MCP1 Stimulate angio/arterogenesis
  • Integrins Receptor for matrix macromolecules, proteinases
  • VE-cadherin, PECAM (CD31)  Endothelial junctional molecules
  • Plasminogen activators, MMPs  Remodel ECM, release and activate growth factors
  • NOS-COX2 Stimulate angiogenesis and vasodilation
  • HIF-1 Activates VEGF and other pro-angiogenic factors
Inhibitors Function
  • VEGFR-1, soluble VEGFR-1, VEGFR-3 Sink for VEGF, PlGF
  • Angiopoietin2 Antagonist for Angiopoietin1
  • Trombospondin1,-2 Inhibit endothelial migration, growth, adhesion and survival
  • Angiostatin Suppress tumor angiogenesis
  • Endostatin (collagen XVIII fragment) Inhibit endothelial survival and migration
  • TIMP InhibitsMMP
  • IL-4, IL-12, IL-8, IFN-α,-ß,-ƴ Inhibit endothelial migration, down regulatebFGF
Table 1. Examples of activators and inhibitors of angiogenesis and their known func-
tions. (Carmeliet et al 2000)